These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26847353)

  • 1. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis.
    Maker AV; August C; Maker VK; Weisenberg E
    J Gastrointest Surg; 2016 Apr; 20(4):869-70. PubMed ID: 26847353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.
    Vouche M; Lewandowski RJ; Atassi R; Memon K; Gates VL; Ryu RK; Gaba RC; Mulcahy MF; Baker T; Sato K; Hickey R; Ganger D; Riaz A; Fryer J; Caicedo JC; Abecassis M; Kulik L; Salem R
    J Hepatol; 2013 Nov; 59(5):1029-36. PubMed ID: 23811303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
    Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contra-lateral liver lobe hypertrophy after unilobar Y90 radioembolization: an alternative to portal vein embolization?
    Teo JY; Goh BK
    World J Gastroenterol; 2015 Mar; 21(11):3170-3. PubMed ID: 25805922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Y-90 Radioembolization After Prior Major Hepatic Resection.
    Zimmermann M; Schulze-Hagen M; Liebl M; Pedersoli F; Goerg F; Ulmer TF; Heinzel A; Isfort P; Kuhl C; Bruners P
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1206-1212. PubMed ID: 28357572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up.
    Henry LR; Hostetter RB; Ressler B; Bowser I; Yan M; Vaghefi H; Abad J; Gulec S; Schwarz RE
    Ann Surg Oncol; 2015 Feb; 22(2):467-74. PubMed ID: 25190114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Wright GP; Marsh JW; Varma MK; Doherty MG; Bartlett DL; Chung MH
    Ann Surg Oncol; 2017 Apr; 24(4):906-913. PubMed ID: 27878478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of prior hepatectomy on the safety and efficacy of radioembolization with yttrium-90 microspheres for patients with unresectable liver tumors.
    Bester L; Feitelson S; Milner B; Chua TC; Morris DL
    Am J Clin Oncol; 2014 Oct; 37(5):454-60. PubMed ID: 23388564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis?
    Pellerin O; Lin M; Bhagat N; Shao W; Geschwind JF
    Cancer Biother Radiopharm; 2013; 28(6):459-65. PubMed ID: 23484809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
    Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S
    AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.
    Ali R; Riaz A; Gabr A; Abouchaleh N; Mora R; Al Asadi A; Caicedo JC; Abecassis M; Katariya N; Maddur H; Kulik L; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2195-2202. PubMed ID: 28812136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.
    Damm R; Seidensticker R; Ulrich G; Breier L; Steffen IG; Seidensticker M; Garlipp B; Mohnike K; Pech M; Amthauer H; Ricke J
    BMC Cancer; 2016 Jul; 16():509. PubMed ID: 27439702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.
    Khalaf H; Alsuhaibani H; Al-Sugair A; Al-Mana H; Al-Mutawa A; Al-Kadhi Y; Al-Sebayel M
    Transplant Proc; 2010 Apr; 42(3):994-8. PubMed ID: 20430224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.
    Teo JY; Allen JC; Ng DC; Choo SP; Tai DW; Chang JP; Cheah FK; Chow PK; Goh BK
    HPB (Oxford); 2016 Jan; 18(1):7-12. PubMed ID: 26776845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization.
    Fan KY; Wild AT; Halappa VG; Kumar R; Ellsworth S; Ziegler M; Garg T; Rosati LM; Su Z; Hacker-Prietz A; Pawlik TM; Cosgrove DP; Hong KK; Kamel IR; Geschwind JF; Herman JM
    Contemp Clin Trials; 2016 Sep; 50():143-9. PubMed ID: 27520932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.
    Lewandowski RJ; Memon K; Mulcahy MF; Hickey R; Marshall K; Williams M; Salzig K; Gates VL; Atassi B; Vouche M; Atassi R; Desai K; Hohlastos E; Sato K; Habib A; Kircher S; Newman SB; Nimeiri H; Benson AB; Salem R
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1861-9. PubMed ID: 24906565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
    Ettorre GM; Levi Sandri GB; Laurenzi A; Colasanti M; Meniconi RL; Lionetti R; Santoro R; Lepiane P; Sciuto R; Pizzi G; Cianni R; Golfieri R; D'Offizi G; Pellicelli AM; Antonini M; Vennarecci G
    World J Surg; 2017 Jan; 41(1):241-249. PubMed ID: 27495316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Radioembolization in Metastatic Neuroendocrine Tumors.
    Lewandowski RJ; Toskich BB; Brown DB; El-Haddad G; Padia SA
    Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1590-1598. PubMed ID: 35918431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization.
    Rubin D; Nutting C; Jones B
    Integr Cancer Ther; 2004 Sep; 3(3):262-7. PubMed ID: 15312272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystitis induced by Yttrium-90 radioembolization of advanced liver tumors: prospective evaluation of a management algorithm in 197 consecutive patients.
    Damm R; Bregenzer C; Steffen I; Amthauer H; Seidensticker R; Seidensticker M; Omari J; Ricke J; Pech M
    Acta Radiol; 2023 Oct; 64(10):2783-2790. PubMed ID: 37525508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.